Published in Br J Pharmacol on May 01, 1995
Molecular and functional properties of P2X receptors--recent progress and persisting challenges. Purinergic Signal (2012) 1.31
Characterization of a P2X-purinoceptor in cultured neurones of the rat dorsal root ganglia. Br J Pharmacol (1996) 1.15
Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels. Br J Pharmacol (2000) 1.10
Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed. Br J Pharmacol (1996) 0.86
ATP-gated cation channels (P2X purinoceptors) in trigeminal mesencephalic nucleus neurons of the rat. J Physiol (1997) 0.84
Adenosine 5'-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland. Br J Pharmacol (2003) 0.83
High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes. Br J Pharmacol (1996) 0.82
An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic nerve terminal. Proc Natl Acad Sci U S A (1996) 0.82
A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors. Br J Pharmacol (1996) 0.80
Effects of adenine nucleosides and nucleotides on neuromuscular transmission to the prostatic stroma of the rat. Br J Pharmacol (2000) 0.80
P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig. Br J Pharmacol (1996) 0.78
The binding characteristics of a human bladder recombinant P2X purinoceptor, labelled with [3H]-alpha beta meATP, [35S]-ATP gamma S or [33P]-ATP. Br J Pharmacol (1996) 0.78
Dissociation of P2 purinoceptor-mediated increase in intracellular Ca2+ level from myosin light chain phosphorylation and contraction in rat aorta. Br J Pharmacol (1996) 0.76
Comparative analysis of P2X1, P2X2, P2X3, and P2X4 receptor subunits in rat nodose ganglion neurons. PLoS One (2014) 0.76
An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem (1979) 13.55
A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. J Physiol (1982) 10.42
Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol (1985) 9.20
Extracellular ATP: effects, sources and fate. Biochem J (1986) 8.45
A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature (1994) 5.43
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
ATP receptor-mediated synaptic currents in the central nervous system. Nature (1992) 4.57
Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol (1988) 4.52
Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol (1984) 4.17
Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther (1994) 3.93
Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett (1993) 3.38
Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol (1984) 3.24
Assay of inorganic and organic phosphorus in the 0.1-5 nanomole range. Anal Biochem (1975) 3.06
ATP mediates fast synaptic transmission in mammalian neurons. Nature (1992) 2.87
Overview. Purinergic mechanisms. Ann N Y Acad Sci (1990) 2.66
G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol Sci (1994) 2.57
P1- and P2-purinoceptor subtypes--an update. Arch Int Pharmacodyn Ther (1990) 2.22
Signalling via ATP in the nervous system. Trends Neurosci (1994) 2.15
ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor. Eur J Pharmacol (1986) 2.07
The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol (1987) 1.94
Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci (1991) 1.87
An ATP-sensitive conductance in single smooth muscle cells from the rat vas deferens. J Physiol (1988) 1.78
The properties of the ATP-induced depolarization and current in single cells isolated from the guinea-pig urinary bladder. Br J Pharmacol (1990) 1.74
Outward currents in rabbit pulmonary artery cells dissociated with a new technique. Exp Physiol (1991) 1.72
Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflugers Arch (1995) 1.69
Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br J Pharmacol (1994) 1.53
Discrete events measure single quanta of adenosine 5'-triphosphate secreted from sympathetic nerves of guinea-pig and mouse vas deferens. Neuroscience (1984) 1.53
Adenosine triphosphate-activated inward current in isolated smooth muscle cells from rat vas deferens. Pflugers Arch (1987) 1.43
Evidence to support the hypothesis that ATP is a co-transmitter in rat vas deferens. Experientia (1983) 1.41
The changing face of autonomic neurotransmission. Acta Physiol Scand (1986) 1.41
Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig. J Auton Pharmacol (1992) 1.06
Effects of alpha,beta-methylene ATP on biphasic responses of rat vas deferens. Eur J Pharmacol (1987) 1.04
Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification. Br J Pharmacol (1994) 1.01
Pharmacological characterization of purinergic receptors in the rat vas deferens. J Pharmacol Exp Ther (1983) 0.91
Adrenergic and 'non-adrenergic' contributions to the two-component tetanus in the rat vas deferens. Eur J Pharmacol (1987) 0.83
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol Rev (1996) 13.17
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83
A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature (1994) 5.43
Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature (1995) 5.38
Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity (2001) 4.23
Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol (1976) 3.95
Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci (1996) 3.71
Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol (2000) 3.44
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
An electrophysiological analysis of the effects of noradrenaline and alpha-receptor antagonists on neuromuscular transmission in mammalian muscular arteries. Br J Pharmacol (1980) 3.06
ATP mediates fast synaptic transmission in mammalian neurons. Nature (1992) 2.87
Pore dilation of neuronal P2X receptor channels. Nat Neurosci (1999) 2.81
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem (1997) 2.78
Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins (1982) 2.73
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol Pharmacol (1995) 2.50
Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A (1987) 2.48
An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J (1996) 2.48
Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol (2000) 2.47
GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol (1989) 2.39
Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol (1999) 2.37
Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J (2001) 2.34
Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology (1997) 2.24
5-HT3 receptors are membrane ion channels. Nature (1989) 2.21
Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor. J Biol Chem (2000) 2.08
Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J Physiol (1996) 2.07
Cytosolic Ca2+, exocytosis, and endocytosis in single melanotrophs of the rat pituitary. Neuron (1990) 2.06
A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol (1985) 2.06
Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J (1997) 2.02
Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology (1997) 1.96
Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol (1998) 1.94
Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors. Mol Pharmacol (1998) 1.91
Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci (1995) 1.90
Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci U S A (1996) 1.86
Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol (1980) 1.86
P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur J Neurosci (1998) 1.85
Inhibitory synaptic potentials resulting from alpha 2-adrenoceptor activation in guinea-pig submucous plexus neurones. J Physiol (1985) 1.85
Electrophysiological properties of P2X-purinoceptors in rat superior cervical, nodose and guinea-pig coeliac neurones. J Physiol (1995) 1.79
A comparative study of neuromuscular transmission in several mammalian muscular arteries. Pflugers Arch (1980) 1.76
Somatostatin increases an inwardly rectifying potassium conductance in guinea-pig submucous plexus neurones. J Physiol (1987) 1.76
Contribution of individual subunits to the multimeric P2X(2) receptor: estimates based on methanethiosulfonate block at T336C. Mol Pharmacol (1999) 1.70
Two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature? [proceedings]. Br J Pharmacol (1977) 1.67
Slow excitatory synaptic potentials recorded from neurones of guinea-pig submucous plexus. J Physiol (1984) 1.64
GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol (1994) 1.64
AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation (1985) 1.63
Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol (1991) 1.61
Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system. J Physiol (1985) 1.57
5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol (1983) 1.55
Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X(2) receptor. J Biol Chem (2001) 1.55
5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol (1989) 1.55
Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. J Neurophysiol (1997) 1.54
Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.52
Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br J Pharmacol (1997) 1.46
Identification of putative 5-HT4 receptors in guinea-pig ascending colon. Eur J Pharmacol (1991) 1.46
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev (1995) 1.45
Blockade of human P2X7 receptor function with a monoclonal antibody. Blood (1998) 1.45
P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene (2011) 1.45
Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br J Pharmacol (1992) 1.43
Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology (1984) 1.43
Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br J Pharmacol (1989) 1.39
A method for quantitating platelet aggregation and analyzing drug-receptor interactions on platelets in whole blood in vitro. J Pharmacol Methods (1981) 1.39
The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol (1989) 1.39
Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology (1994) 1.37
Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol (1999) 1.34
Membrane topology of an ATP-gated ion channel (P2X receptor). J Biol Chem (1998) 1.32
5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol (1989) 1.31
Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol (1997) 1.30
Naratriptan: biological profile in animal models relevant to migraine. Cephalalgia (1997) 1.30
P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol (1998) 1.29
Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br J Pharmacol (2006) 1.29
Effects of antagonists at the human recombinant P2X7 receptor. Br J Pharmacol (1998) 1.28
Ketanserin--a novel antihypertensive drug? J Pharm Pharmacol (1982) 1.28
Vasodilatation of arterioles by acetylcholine released from single neurones in the guinea-pig submucosal plexus. J Physiol (1990) 1.28
U-46619, a selective thromboxane A2-like agonist? [proceedings]. Br J Pharmacol (1980) 1.28
Pharmacological and anti-emetic properties of ondansetron. Eur J Cancer Clin Oncol (1989) 1.25
Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist. Br J Pharmacol (1989) 1.25
Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype. Br J Pharmacol (1991) 1.24
The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones. J Physiol (1998) 1.21
Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett (1998) 1.21
Complexities of measuring antagonist potency at P2X(7) receptor orthologs. J Pharmacol Exp Ther (2001) 1.20
2',3'-O-(2,4,6- trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP)--a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels. Br J Pharmacol (1998) 1.20
Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery. J Biol Chem (2001) 1.20
The effects of uptake1 on alpha-adrenoceptor antagonist potency in dog saphenous vein. Br J Pharmacol (1978) 1.19
5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats. Br J Pharmacol (1986) 1.17
Functional characterization of the P2X(4) receptor orthologues. Br J Pharmacol (2000) 1.16
Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J Biol Chem (2001) 1.16
The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia (1989) 1.16
Desensitization of the P2X(2) receptor controlled by alternative splicing. FEBS Lett (1997) 1.15
Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br J Pharmacol (1991) 1.15
Calcium permeability and block at homomeric and heteromeric P2X2 and P2X3 receptors, and P2X receptors in rat nodose neurones. J Physiol (1998) 1.15
Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.15
Apparent species differences in the kinetic properties of P2X(7) receptors. Br J Pharmacol (2000) 1.14
Cholera toxin-sensitive neurons in guinea pig submucosal plexus. Am J Physiol (1993) 1.13
Neural reflexes controlling intestinal microcirculation. Am J Physiol (1996) 1.12
Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Br J Pharmacol (1979) 1.12
P2X1 receptor activation in HL60 cells. Blood (1996) 1.11
Excitatory effect of P2X receptor activation on mesenteric afferent nerves in the anaesthetised rat. J Physiol (1999) 1.11